Michael Dolton
Impact in
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Antifungal resistance and susceptibility 9
-
- Antibiotics Pharmacokinetics and Efficacy 4
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Andrew J. McLachlan (12 shared papers)John E. Ray (4 shared papers)Lisa Pont (4 shared papers)Kingsley Ng (2 shared papers)Sharon C.-A. Chen (2 shared papers)Deborah Marriott (1 shared paper)Dorothy Cheung (4 shared papers)David F. Choy (3 shared papers)
- Journals
- Journal of Pharmaceutical Sciences (7 papers)Antimicrobial Agents and Chemotherapy (6 papers)CPT Pharmacometrics & Systems Pharmacology (4 papers)Journal of Allergy and Clinical Immunology (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)
- Partner nations
- United StatesAustraliaFrance
In The Last Decade
Michael Dolton
39 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 93
- Infectious Diseases 732
- Pharmacology 232
- Epidemiology 386
- Immunology and Allergy 56
- Physiology 207
Countries citing papers authored by Michael Dolton
This map shows the geographic impact of Michael Dolton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Dolton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Dolton more than expected).
Fields of papers citing papers by Michael Dolton
This network shows the impact of papers produced by Michael Dolton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Dolton. The network helps show where Michael Dolton may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Dolton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 231 | |
| 2 | 2021 | 208 | |
| 3 | 2012 | 158 | |
| 4 | 2012 | 117 | |
| 5 | 2014 | 88 | |
| 6 | 2014 | 79 | |
| 7 | 2014 | 70 | |
| 8 | 2019 | 68 | |
| 9 | 2009 | 56 | |
| 10 | 2012 | 52 | |
| 11 | 2022 | 46 | |
| 12 | 2020 | 43 | |
| 13 | 2013 | 32 | |
| 14 | 2016 | 22 | |
| 15 | 2014 | 21 | |
| 16 | 2021 | 17 | |
| 17 | 2022 | 16 | |
| 18 | 2022 | 14 | |
| 19 | 2023 | 13 | |
| 20 | 2014 | 12 |
About Michael Dolton
Michael Dolton is a scholar working on Infectious Diseases, Pharmacology, Physiology, Pharmaceutical Science and Oncology, having authored 40 papers that have together received 1.5k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (9 papers), Alzheimer's disease research and treatments (5 papers), Drug Solubulity and Delivery Systems (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Computational Drug Discovery Methods (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Infectious Diseases (732 citations), Pharmacology (232 citations), Epidemiology (386 citations), Immunology and Allergy (56 citations) and Physiology (207 citations). Michael Dolton has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Andrew J. McLachlan, John E. Ray, Lisa Pont, Kingsley Ng, Sharon C.-A. Chen, Deborah Marriott, Dorothy Cheung, David F. Choy, Wiebke Theess and Weily Soong. Their work appears in journals such as Journal of Pharmaceutical Sciences, Antimicrobial Agents and Chemotherapy, CPT Pharmacometrics & Systems Pharmacology, Journal of Allergy and Clinical Immunology and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.